Form 8-K - Current report:
SEC Accession No. 0001683168-21-003188
Filing Date
2021-07-30
Accepted
2021-07-30 17:30:27
Documents
3
Period of Report
2021-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm 8-K 23603
2 LEGAL OPINION sonoma_8k0501.htm EX-5.1 8844
3 AT THE MARKET OFFERING AGREEMENT sonoma_8k-ex1001.htm EX-10.1 217234
  Complete submission text file 0001683168-21-003188.txt   250895
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 211133779
SIC: 2834 Pharmaceutical Preparations